Premium
Photopharmacology in Alzheimer's Disease
Author(s) -
RodríguezSoacha Diego Alejandro,
Decker Michael
Publication year - 2018
Publication title -
advanced therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0ISSN - 2366-3987
DOI - 10.1002/adtp.201800037
Subject(s) - neuroscience , acetylcholinesterase , muscarinic acetylcholine receptor , acetylcholine , disease , nmda receptor , alzheimer's disease , endocannabinoid system , biology , chemistry , receptor , medicine , pharmacology , biochemistry , enzyme
In this report, the advances of photopharmacology as a method that allows the study of therapeutically relevant target proteins for Alzheimer's disease (AD) with high spatiotemporal resolution through photoswitchable molecules that are manipulated by light irradiation will be presented. The chemical and biophysical basics of the design of photoswitchable drugs are considered, as well as their current specific applications in the development of tool compounds to investigate functions of acetylcholinesterase, muscarinic acetylcholine, cannabinoid, and NMDA receptors, respectively. All of them represent highly important AD targets.